BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17203088)

  • 1. Drug insight: the role of albumin in the management of chronic liver disease.
    Wong F
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4(1):43-51. PubMed ID: 17203088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin for end-stage liver disease.
    Lee JS
    Korean J Intern Med; 2012 Mar; 27(1):13-9. PubMed ID: 22403494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin infusion in liver cirrhotic patients.
    Rena NM; Wibawa ID
    Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
    ;
    Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [When should we give albumin in patients with cirrhosis?].
    Bochatay L; Elkrief L; Spahr L
    Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current indications for the use of albumin in the treatment of cirrhosis.
    Alves de Mattos A
    Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of albumin in patients with decompensated cirrhosis: the case in favor.
    Maor Y
    Isr Med Assoc J; 2005 Feb; 7(2):115-8. PubMed ID: 15729966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical indications for the albumin use: still a controversial issue.
    Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
    Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin: Indications in chronic liver disease.
    Tufoni M; Zaccherini G; Caraceni P; Bernardi M
    United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V; Fernandez J; Ginès P
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
    Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
    Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
    Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.
    Garcia-Martinez R; Caraceni P; Bernardi M; Gines P; Arroyo V; Jalan R
    Hepatology; 2013 Nov; 58(5):1836-46. PubMed ID: 23423799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [News for usage of albumin in patients with liver disease].
    Cremonese C; Uschner FE; Trebicka J
    Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
    Guevara M; Terra C; Nazar A; Solà E; Fernández J; Pavesi M; Arroyo V; Ginès P
    J Hepatol; 2012 Oct; 57(4):759-65. PubMed ID: 22732511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.